Potential serum biomarkers of treatment response to ustekinumab in patients with psoriasis: a pilot study

Br J Dermatol. 2015 Dec;173(6):1536-9. doi: 10.1111/bjd.13997. Epub 2015 Nov 25.

Authors

A J Onderdijk^{1

2}, A S Ijpma³, S P Menting⁴, E M Baerveldt⁵, E P Prens^{1

2}

Affiliations

¹ Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands.
² Department of Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands.
³ Department of Bioinformatics, Erasmus University Medical Center, Rotterdam, the Netherlands.
⁴ Department of Dermatology, Academic Medical Center, Amsterdam, the Netherlands.
⁵ Department of Dermatology, Havenziekenhuis, Rotterdam, the Netherlands.

PMID: 26134667
DOI: 10.1111/bjd.13997

No abstract available

Publication types

Letter

MeSH terms

Biomarkers / metabolism
Cytokines / metabolism
Dermatologic Agents / therapeutic use*
Humans
Pilot Projects
Psoriasis / drug therapy*
Signal Transduction / physiology
Th1 Cells / metabolism
Th17 Cells / metabolism
Treatment Outcome
Up-Regulation / physiology
Ustekinumab / therapeutic use*

Substances

Biomarkers
Cytokines
Dermatologic Agents
Ustekinumab